Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Routine imaging guided by a 31-gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies.
Dhillon S, Duarte-Bateman D, Fowler G, Hagstrom MNE, Lampley N, Olivares S, Fumero-Velázquez MS, Vu K, Wayne JD, Gastman BR, Vetto J, Gerami P. Dhillon S, et al. Arch Dermatol Res. 2023 Oct;315(8):2295-2302. doi: 10.1007/s00403-023-02613-6. Epub 2023 Mar 28. Arch Dermatol Res. 2023. PMID: 36977840 Free PMC article.
Correction to: Routine imaging guided by a 31‑gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies.
Dhillon S, Duarte-Bateman D, Fowler G, Hagstrom MNE, Lampley N, Olivares S, Fumero-Velázquez MS, Vu K, Wayne JD, Gastman BR, Vetto J, Gerami P. Dhillon S, et al. Arch Dermatol Res. 2023 Oct;315(8):2303. doi: 10.1007/s00403-023-02622-5. Arch Dermatol Res. 2023. PMID: 37043011 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 37060399
Correction: Routine imaging guided by a 31‑gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies.
Dhillon S, Duarte-Bateman D, Fowler G, Hagstrom MNE, Lampley N, Olivares S, Fumero-Velázquez MS, Vu K, Wayne JD, Gastman BR, Vetto J, Gerami P. Dhillon S, et al. Arch Dermatol Res. 2023 Nov 25;316(1):6. doi: 10.1007/s00403-023-02733-z. Arch Dermatol Res. 2023. PMID: 38006425 Free PMC article. No abstract available.
Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: A multicenter cohort study.
Shannon AB, Sharon CE, Straker RJ 3rd, Carr MJ, Sinnamon AJ, Bogatch K, Thaler A, Kelly N, Vetto JT, Fowler G, DePalo D, Sondak VK, Miura JT, Faries MB, Bartlett EK, Zager JS, Karakousis GC. Shannon AB, et al. Among authors: vetto jt. J Am Acad Dermatol. 2023 Jan;88(1):52-59. doi: 10.1016/j.jaad.2022.09.040. Epub 2022 Sep 30. J Am Acad Dermatol. 2023. PMID: 36184008
151 results